Webinars / Podcasts
As we enter the second quarter of 2020, a major SEND milestone has been reached with the requirement of SEND v3.1 for both IND and BLA/NDA study submissions. See how this impacts your submission and the increased scope of the standard within this update.
Bioanalytical Project Management — a Critical Function Adapted to the Study Type(s) of Your Drug Development Program
The objective of quantitative bioanalysis is to provide precise and accurate sample analysis results within the acceptable tolerance (variability) and study scope, so that sponsors can makego/no-go decisions.